Product Information
UBRELVY 100 MG TABLET is a brand product labeled by Allergan, Inc., priced at $109.1352 per EA under NDC 00023650116. Its NADAC has been published 217 times since Jun 29, 2022.
FDA first approved this application on Dec 23, 2019.
Strength
100 mg/1
Manufacturer
Allergan, Inc.NDC
00023650116
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
UBROGEPANTApproval Type
New Drug (NDA)
FDA Application
NDA211765FDA Approved
12/23/2019
On Market Since
12/23/2019
Pharmacological Classes
Price Statistics
The NADAC for UBRELVY 100 MG TABLET has been published 217 times since Jun 29, 2022, and over the history we have for it it has risen 21.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $109.1352 per EA |
|---|---|
| All-time high | $109.1882 (May 13, 2026) |
| All-time low | $90.0749 (Jun 29, 2022) |
| 52-week high | $109.1882 |
| 52-week low | $103.9470 |
| Median price | $99.1876 |
| Average price | $99.5467 |
| Largest weekly change | +5.0% (Jan 10, 2024) |
| Weeks tracked | 217 |
| Tracking since | Jun 29, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of UBRELVY 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for UBRELVY 100 MG TABLET, manufactured by Allergan, Inc., is $109.1352 per EA (NDC 00023650116), effective Aug 19, 2026.
How has the price of UBRELVY 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for UBRELVY 100 MG TABLET has risen 21.2%. It has been tracked across 217 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for UBRELVY 100 MG TABLET?
Since Jun 29, 2022, the NADAC for UBRELVY 100 MG TABLET has ranged from a low of $90.0749 (Jun 29, 2022) to a high of $109.1882 (May 13, 2026), with a median of $99.1876 per EA.
Are there cheaper alternatives to UBRELVY 100 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as UBRELVY 100 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures UBRELVY 100 MG TABLET?
UBRELVY 100 MG TABLET (NDC 00023650116) is labeled by Allergan, Inc., and CMS classifies it as a brand product.